Literature DB >> 30165064

Development of T cell lines sensitive to antigen stimulation.

Theodore Williams1, Harsha S Krovi2, Laurie G Landry1, Frances Crawford3, Niyun Jin1, Anita Hohenstein1, Megan E DeNicola4, Aaron W Michels1, Howard W Davidson5, Sally C Kent4, Laurent Gapin2, John W Kappler6, Maki Nakayama7.   

Abstract

Immortalized T cells such as T cell hybridomas, transfectomas, and transductants are useful tools to study tri-molecular complexes consisting of peptide, MHC, and T cell receptor (TCR) molecules. These cells have been utilized for antigen discovery studies for decades due to simplicity and rapidness of growing cells. However, responsiveness to antigen stimulation is typically less sensitive compared to primary T cells, resulting in occasional false negative outcomes especially for TCRs having low affinity to a peptide-MHC complex (pMHC). To overcome this obstacle, we genetically engineered T cell hybridomas to express additional CD3 molecules as well as CD4 with two amino acid substitutions that increase affinity to MHC class II molecules. The manipulated T cell hybridomas that were further transduced with retroviral vectors encoding TCRs of interest responded to cognate antigens more robustly than non-manipulated cells without evoking non-antigen specific reactivity. Of importance, the manipulation with CD3 and mutated human CD4 expression was effective in increasing responsiveness of T cell hybridomas to a wide variety of TCR, peptide, and MHC combinations across class II genetic loci (i.e. HLA-DR, HLA-DQ, HLA-DP, and murine H2-IA) and species (i.e. both humans and mice), and thus will be useful to identify antigen specificity of T cells.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Antigen discovery; CD4; Genetic manipulation; MHC class II; T cell hybridomas

Mesh:

Substances:

Year:  2018        PMID: 30165064      PMCID: PMC8006528          DOI: 10.1016/j.jim.2018.08.011

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  39 in total

1.  Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.

Authors:  Vimukthi Pathiraja; Janine P Kuehlich; Peter D Campbell; Balasubramanian Krishnamurthy; Thomas Loudovaris; P Toby H Coates; Thomas C Brodnicki; Philip J O'Connell; Katherine Kedzierska; Christine Rodda; Philip Bergman; Erin Hill; Anthony W Purcell; Nadine L Dudek; Helen E Thomas; Thomas W H Kay; Stuart I Mannering
Journal:  Diabetes       Date:  2014-08-25       Impact factor: 9.461

2.  HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.

Authors:  Stig Tollefsen; Helene Arentz-Hansen; Burkhard Fleckenstein; Oyvind Molberg; Melinda Ráki; William W Kwok; Günther Jung; Knut E A Lundin; Ludvig M Sollid
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

3.  Development and function of T cells in T cell antigen receptor/CD3 zeta knockout mice reconstituted with Fc epsilon RI gamma.

Authors:  C P Liu; W J Lin; M Huang; J W Kappler; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.

Authors:  Aaron W Michels; Laurie G Landry; Kristen A McDaniel; Liping Yu; Martha Campbell-Thompson; William W Kwok; Kenneth L Jones; Peter A Gottlieb; John W Kappler; Qizhi Tang; Bart O Roep; Mark A Atkinson; Clayton E Mathews; Maki Nakayama
Journal:  Diabetes       Date:  2016-12-05       Impact factor: 9.461

5.  Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes.

Authors:  P Eerligh; M van Lummel; A Zaldumbide; A K Moustakas; G Duinkerken; G Bondinas; B P C Koeleman; G K Papadopoulos; B O Roep
Journal:  Genes Immun       Date:  2011-05-12       Impact factor: 2.676

6.  T cell receptor restriction of diabetogenic autoimmune NOD T cells.

Authors:  E Simone; D Daniel; N Schloot; P Gottlieb; S Babu; E Kawasaki; D Wegmann; G S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response.

Authors:  S Pan; T Trejo; J Hansen; M Smart; C S David
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

8.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.

Authors:  Andrea L Szymczak; Creg J Workman; Yao Wang; Kate M Vignali; Smaroula Dilioglou; Elio F Vanin; Dario A A Vignali
Journal:  Nat Biotechnol       Date:  2004-04-04       Impact factor: 54.908

9.  Domain-swapped T cell receptors improve the safety of TCR gene therapy.

Authors:  Michael T Bethune; Marvin H Gee; Mario Bunse; Mark S Lee; Eric H Gschweng; Meghana S Pagadala; Jing Zhou; Donghui Cheng; James R Heath; Donald B Kohn; Michael S Kuhns; Wolfgang Uckert; David Baltimore
Journal:  Elife       Date:  2016-11-08       Impact factor: 8.140

10.  The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4.

Authors:  D M Altmann; D C Douek; A J Frater; C M Hetherington; H Inoko; J I Elliott
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Rationally designed small molecules to prevent type 1 diabetes.

Authors:  David A Ostrov; Peter A Gottlieb; Aaron W Michels
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-04       Impact factor: 3.243

2.  How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes.

Authors:  Yang Wang; Tomasz Sosinowski; Andrey Novikov; Frances Crawford; Janice White; Niyun Jin; Zikou Liu; Jinhao Zou; David Neau; Howard W Davidson; Maki Nakayama; William W Kwok; Laurent Gapin; Philippa Marrack; John W Kappler; Shaodong Dai
Journal:  Sci Immunol       Date:  2019-04-05

3.  Multiplex T-cell Stimulation Assay Utilizing a T-cell Activation Reporter-based Detection System.

Authors:  Laurie G Landry; Sarah E Mann; Amanda M Anderson; Maki Nakayama
Journal:  Bio Protoc       Date:  2021-01-20

Review 4.  Hidden in Plain View: Discovery of Chimeric Diabetogenic CD4 T Cell Neo-Epitopes.

Authors:  Brendan K Reed; John W Kappler
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

Review 5.  Determining Antigen Specificity of Human Islet Infiltrating T Cells in Type 1 Diabetes.

Authors:  Maki Nakayama; Aaron W Michels
Journal:  Front Immunol       Date:  2019-03-08       Impact factor: 7.561

6.  Inherent reactivity of unselected TCR repertoires to peptide-MHC molecules.

Authors:  S Harsha Krovi; John W Kappler; Philippa Marrack; Laurent Gapin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

7.  Multiplex T Cell Stimulation Assay Utilizing a T Cell Activation Reporter-Based Detection System.

Authors:  Sarah E Mann; Zhicheng Zhou; Laurie G Landry; Amanda M Anderson; Aimon K Alkanani; Jeremy Fischer; Mark Peakman; Roberto Mallone; Kristen Campbell; Aaron W Michels; Maki Nakayama
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

8.  Proinsulin-Reactive CD4 T Cells in the Islets of Type 1 Diabetes Organ Donors.

Authors:  Laurie G Landry; Amanda M Anderson; Holger A Russ; Liping Yu; Sally C Kent; Mark A Atkinson; Clayton E Mathews; Aaron W Michels; Maki Nakayama
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-25       Impact factor: 5.555

9.  Protecting Stem Cell Derived Pancreatic Beta-Like Cells From Diabetogenic T Cell Recognition.

Authors:  Roberto Castro-Gutierrez; Aimon Alkanani; Clayton E Mathews; Aaron Michels; Holger A Russ
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-09       Impact factor: 5.555

10.  Gene Expression-Based Identification of Antigen-Responsive CD8+ T Cells on a Single-Cell Level.

Authors:  Yannick F Fuchs; Virag Sharma; Anne Eugster; Gloria Kraus; Robert Morgenstern; Andreas Dahl; Susanne Reinhardt; Andreas Petzold; Annett Lindner; Doreen Löbel; Ezio Bonifacio
Journal:  Front Immunol       Date:  2019-11-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.